Yardley, Pennsylvania—3 March 2015 – Mapi incorporates the expertise of CanReg in supporting our clients Regulatory challenges through the drug development and commercialization process. Mapi Group ...

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ:ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that ...

YARDLEY, Pennsylvania, Sept. 10, 2014 /PRNewswire/ -- Since 1974 Mapi has lead Patient-Centred Research and pioneered industry wide innovations in Pharmaceutical Market Research, Cross-Cultural ...

YARDLEY, Pa., Oct. 30, 2014 /PRNewswire/ -- Mapi, a global leader in Real-World Evidence, Health Economics & Outcomes Research (HEOR), Market Access, Epidemiology and Patient-Centered Research ...

The Healthcare services group MAPI has named James M. Karis its Chief Executive Officer. MAPI, a pioneer in Patient Assessment, Late Phase Studies, PharmacoEpidemiology, PharmacoEconomics, PRO ...

LONDON, June 19, 2017 /PRNewswire/ -- Mapi, the leading Patient-Centered Health Research company, today announced the creation of a dedicated unit combining its Patient Centered Outcomes (PCO) team, ...

LONDON, May 2, 2017 /PRNewswire/ -- Mapi, the leading Patient-Centered Health Research and Commercialization company, further expands their footprint in London. Mapi Group today announced the ...

Income at clinical research company Icon increased by 10.7 per cent to over $71.6 million (€61.4 million) in the three months to the end of June compared to the same period in 2016. Announcing its ...

MAPI Consultancy sits at the heart of the MAPI Group and is a leading global expert in Health Economics & Outcomes Research and Strategic Market Access. Our purpose is to generate Patient Reported ...

<table cellspacing=0 cellpadding=0 border=0><tr><td align=right>Copyright: </td><td>(c) 2011 PRWEB.COM Newswire</td></tr><tr><td align=right>Source: </td><td>PR Web ...